PACULit Daily Literature Update: Inhaled isoflurane for sedation of mechanically ventilated children in intensive care (IsoCOMFORT): a multicentre, randomised, active-control, assessor-masked, non-inferiority phase 3 trial
Miatello J, Palacios-Cuesta A, Radell P, et al. Inhaled isoflurane for sedation of mechanically ventilated children in intensive care (IsoCOMFORT): a multicentre, randomised, active-control, assessor-masked, non-inferiority phase 3 trial. Lancet Respir Med. 2025 Jul;:-. doi: S2213-2600(25)00203-6. | PMID: 40680761
Phase 3 Trial
Mechanically ventilated children in intensive care
Inhaled isoflurane sedation
Until ICU discharge
This multicentre, randomised, active-control, assessor-masked, non-inferiority phase 3 trial evaluated the safety and efficacy of inhaled isoflurane compared to standard intravenous sedation in mechanically ventilated children admitted to intensive care units.
Key Learning Points
-
•
Inhaled isoflurane sedation was non-inferior to standard intravenous sedation for sedation effectiveness in ventilated pediatric patients. -
•
The inhaled sedation was well tolerated without significant adverse events and facilitated rapid awakening.
Read Full Study Review
Take Assessment Quiz
🎧 AI Audio Overview